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Abstract. The aim of present investigation was to determine the mole fraction solubility of a poorly water 
soluble antidiabetic drug gliclazide (GLZ) in mono-solvents and various Transcutol + water co-solvent 
mixtures at (298.15 to 333.15) K. The experimental solubility of GLZ was measured by shake flask method 
and resulting data was correlated with the modified Apelblat model at each temperature studied. Good 
correlation was observed between the experimental data of GLZ and calculated one with absolute relative 
deviation in the range of (0.050 to 5.680) %. The correlation coefficients were observed in the range of 
0.9966 to 0.9995 which indicated good fitting of experimental solubility data. The lowest mole fraction 
solubility of GLZ was observed in pure water (1.9 × 10–6 at 298.15 K) whereas the highest one was observed 
in pure Transcutol (11.9 × 10–3 at 298.15 K). The enthalpies and entropies for GLZ dissolution were observed 
as positive values in the range of (15.742 to 40.551) kJ mol–1 and (52.801 to 121.721) J mol–1 K–1, 
respectively in all sample matrices. These results of thermodynamic parameters indicated that the dissolution 
of GLZ is endothermic and an entropy-driven process. Based on current solubility data, GLZ was considered 
as practically insoluble (poorly soluble) in pure water and soluble in Transcutol. These preliminary studies 
indicated that Transcutol could be used as a co-solvent for solubility enhancement of GLZ which could help 
in preformulation studies and formulation development of GLZ.  
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INTRODUCTION 
The IUPAC name of gliclazide (GLZ) is 1-(3,3a,4,5,6, 
6a-hexahydro - 1H - cyclopenta[c]pyrrol - 2 - yl) - 3 - (4 - methyl-
phenyl) sulfonylurea (Figure 1, molecular formula: 
C15H21N3O3S, molecular mass: 323.411 g mol
–1, CAS 
registry number: 21187-98-4).1,2 It is a second genera-
tion hypoglycemic agent which is prescribed in the 
treatment of type 2 diabetes mellitus.1–4 It is very poorly 
soluble drug according to the biopharmaceutical classi-
fication system (BCS) of drugs (BCS class II) due to 
which its dissolution is poor.2,4 Poor solubility and dis-
solution often resulted in poor in vivo absorption of 
such drugs.4 Poor solubility and poor dissolution are the 
main obstacles for formulation development of GLZ.1,2,4 
The aqueous solubility of GLZ at 25 and 37 °C has been 
reported as <40 and 55 µg ml–1, respectively.3,5 Various 
approaches such as surfactants,5 solid dispersions,1,4,6–10 
micronization,11,12 ordered mixing,2 co-grinding13 and 
cyclodextrins complexation14 have been applied to en-
hance solubility and dissolution rate of GLZ. Co-solvent 
approach has also been applied to enhance aqueous 
solubility of seven poorly soluble antidiabetic drugs 
including GLZ.3 Co-solvent technique is error free 
approach which is usually applied for solubilization as 
well as stabilization of drugs/pharmaceuticals in aque-
ous solutions.15,16 Solubility is one of the important 
 
Figure 1. Molecular structure of GLZ 
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physicochemical properties of the drugs because of its 
wide range of applications such as drug crystalliza-
tion/purification, drug dissolution/permeation, prefo 
rmulation studies and formulation development.15–18 
Therefore, solubility data of poorly soluble drugs must 
be determined in wide range of temperatures to get 
complete information about physicochemical character-
ization of drugs.19 The IUPAC name of Transcutol is 
diethylene glycol monoethyl ether which has been in-
vestigated as a cosurfactant in the preparation and char-
acterization of several lipid based formulations such as 
nanoemulsions/microemulsions and self-nanoemulsify-
ing (SNEDDS)/self-microemulsifying (SMEDDS) drug 
delivery systems.17,20–22 These lipid based formulations 
(nanoemulsions/microemulsions and SNEDDS/SMEDDS) 
are known to enhance solubility/dissolution and bioa-
vailability of poorly soluble drugs.20–25 In spite of great 
solubilizing and stabilizing capacity of Transcutol, it has 
never been investigated as a co-solvent to enhance solu-
bility of GLZ in water-co-solvent mixtures in literature 
so far. Therefore, the aim of present investigation was to 
determine the mole fraction solubility of GLZ in mono-
solvents (pure water and pure Transcutol) as well as in 
various Transcutol-water co-solvent mixtures at temper-
ature range from (298.15 to 333.15) K. The experi-
mental mole fraction solubility data was also correlated 
with the modified Apelblat model. These preliminary 
studies could be very useful in the development of lipid 




Gliclazide (mass fraction purity of 0.986) was pur-
chased from Sigma Aldrich (St. Louis, MO). Tarns-
cutol-HP (mass fraction purity of 0.9998) was kindly 
gifted from Gattefosse (Lyon, France). Distilled water 
was obtained from distillation unit in our laboratory. All 
other chemicals used were of analytical grade. The 
general properties of these materials are presented in 
Table 1. 
 
Measurement of GLZ Solubility  
The mole fraction solubility of GLZ against mass frac-
tion of Transcutol (w = 0.0 to 1.0) in Transcutol-water 
co-solvent mixtures was determined by shake flask 
method at various temperatures (298.15 to 333.15) 
K.15,17,18 The excess amount of GLZ was added in 5 g of 
each co-solvents mixture including pure water (w = 0.0) 
and pure Transcutol (w = 1.0) in 10 ml capacity vials in 
triplicate to obtain drug suspensions. Each vial was 
tightly closed. Drug suspension of each co-solvent mix-
ture was then kept in an isothermal mechanical shaker 
bath (Julabo, PA) at shaking speed of 100 rpm for 72 h 
to reach the equilibrium. These experiments were car-
ried out at different temperatures (298.15 to 333.15) K. 
After the period of 72 h, all drug suspensions were tak-
en out from the shaker bath and allowed to settle drug 
particles for the period of 2 h at the bottom of the vi-
als.18,26 All the drug suspensions were filtered using 
0.45 µm filter paper, supernatant from each sample was 
taken and diluted 1000 times with respective solvent/co-
solvent mixture and subjected for analysis of GLZ con-
tent at the wavelength of 227 nm using UV-Visible 
spectrophotometer (SP1900, Axiom, Germany).1,7 The 
proposed analytical method was found to be linear in 
the range of (2 to 50) µg/g with correlation coefficient 
(R2) of 0.999. The standard uncertainty for the tempera-
tures u(T) was observed as ± 0.03 K. However, the rela-
tive standard uncertainty in solubility ur(xe) was found 
to be 0.97 %. The experimental mole fraction solubility 













where m1, m2, and m3 represent the masses (expressed in 
g) of GLZ (solute), Transcutol, and water, respectively. 
M1, M2, and M3 represent the molecular masses (ex-
pressed in g mol–1)of GLZ, Transcutol, and water, re-
spectively. 
 
RESULTS AND DISCUSSION 
Solubility Data of GLZ  
The experimental mole fraction solubility data of GLZ 
in mono-solvents (pure Transcutol and pure water) and 
Transcutol-water co-solvent mixtures at various temper-
atures are listed in Table 2. The solubility of GLZ was 
found to be increased exponentially with temperature in 
all sample matrices. The mole fraction solubility of 
GLZ was found to be lowest in pure water (1.9 × 10–6 at 
Table 1. General properties of GLZ, Transcutol and water 
Materials Molecular formula M / g mol–1 D / g ml–1 Purity / % CAS No. 
GLZ C15H21N3O3S 323.411 1.340 98.60 21187-98-4 
Transcutol C6H14O3 134.170 0.990 99.98 111-90-0 
Water H2O 18.015 1.000 100.00 7732-18-5 
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298.15 K) whereas the highest one was observed in pure 
Transcutol (11.9 × 10–3 at 298.15 K) at each temperature 
studied (Table 2). However, the mole fraction solubility 
of GLZ in pure Transcutol was significantly higher than 
pure water at each temperature studied. The impact of 
mass fraction of Transcutol on mole fraction solubility 
of GLZ at various temperatures is presented in Figure 2. 
The mole fraction solubility of GLZ was found to be 
increased with increase in mass fraction of Transcutol in 
Transcutol-water co-solvent mixtures at each tempera-
ture studied. This was probably due to the reduced po-
larities in co-solvent mixtures as compared to pure wa-
ter which is a highly polar solvent.27 The lowest solubil-
ity of GLZ in pure water was also due to its highest 
polarity.28 It is also very well reported in literature that 
the solubility of drug/solute molecules could be 
enhanced by reducing the polarity of solvents/co-solvent 
mixtures.29 Therefore, increased solubility of GLZ in 
co-solvent mixtures was probably due to reduced polari-
ties.27–29 The solubility data of GLZ in present study was 
in agreement with previous report of polarities. The 
highest mole fraction solubility of GLZ in pure Trans-
cutol was probably due to the lowest polarity of Trans-
cutol. The mole fraction solubility of GLZ in pure water 
at 298.15 and 310.15 K has been reported as <2.23 × 10–6 
and 3.06 × 10–6, respectively.3,5 However, in present stu-
dy the mole fraction solubility of GLZ in pure water at 
298.15 and 308.15 K was observed as 1.9 × 10–6 and 
2.84 × 10–6, respectively which were very close to re-
ported values (Table 2). Based on these results, GLZ 
has been considered as practically insoluble (poorly 
soluble) in pure water and soluble in pure Transcutol. 
Therefore, Transcutol could be utilized as a physiologi-
cally compatible co-solvent in formulation development 
of GLZ in future studies.  
Thermodynamic Modeling of GLZ Solubility 
In present study, the experimental solubility data of 
GLZ was correlated with the modified Apelblat model 
because it is commonly used model applied for both 
polar as well as for nonpolar systems.15,18,26 According 
to this model, the mole fraction solubility of solute is 
temperature-dependent which can be represented by 
equation 2 to describe solid-liquid equilibrium:18,30 
 ln  lnBx A C T
T
    (2) 
Where, x represents the calculated/Apelblat solubility of 
GLZ. T represents the absolute temperature (in K) and 
parameters A, B, and C are adjustable model parameters. 
Figure 2. Effect of mass fraction of Transcutol on mole frac-
tion solubility (xe) of GLZ at various temperatures. 
Table 2. Experimental mole fraction solubilities (xe) of crystalline GLZ against mass fraction of Transcutol (w) in various Trans-
cutol + water co-solvent mixtures in the absence of solute at temperatures T = (298.15 to 333.15) K and pressure p = 0.1 MPa (the 
standard uncertainty for the temperatures u(T ) is ± 0.03 K, the relative standard uncertainty in solubility ur(xe) is 0.97 %) 
w 
xe 
T = 298.15 K T = 303.15 K T = 308.15 K T = 313.15 K T = 318.15 K T = 323.15 K T = 328.15 K T = 333.15 K
0.0 1.95 × 10–6 2.34 × 10–6 2.84 × 10–6 3.51 × 10–6 4.23 × 10–6 5.07 × 10–6 6.02 × 10–6 7.02 × 10–6 
0.1 1.21 × 10–4 1.52 × 10–4 1.95 × 10–4 2.63 × 10–4 3.32 × 10–4 4.08 × 10–4 5.01 × 10–4 6.08 × 10–4 
0.2 2.55 × 10–4 3.09 × 10–4 3.63 × 10–4 4.30 × 10–4 4.98 × 10–4 5.79 × 10–4 6.79 × 10–4 7.87 × 10–4 
0.3 3.91 × 10–4 4.66 × 10–4 5.56 × 10–4 6.61 × 10–4 7.81 × 10–4 9.09 × 10–4 1.05 × 10–3 1.20 × 10–3 
0.4 6.30 × 10–4 7.15 × 10–4 8.34 × 10–4 9.53 × 10–4 1.08 × 10–3 1.20 × 10–3 1.33 × 10–3 1.49 × 10–3 
0.5 1.50 × 10–3 1.76 × 10–5 2.05 × 10–3 2.31 × 10–3 2.62 × 10–3 2.95 × 10–3 3.33 × 10–3 3.65 × 10–3 
0.6 1.89 × 10–3 2.10 × 10–3 2.46 × 10–3 2.86 × 10–3 3.26 × 10–3 3.78 × 10–3 4.25 × 10–3 4.63 × 10–3 
0.7 2.53 × 10–3 2.90 × 10–3 3.22 × 10–4 3.77 × 10–3 4.19 × 10–3 4.79 × 10–3 5.38 × 10–3 6.09 × 10–3 
0.8 3.79 × 10–3 4.25 × 10–3 4.70 × 10–3 5.47 × 10–3 6.21 × 10–3 6.80 × 10–3 7.55 × 10–3 8.53 × 10–3 
0.9 6.21 × 10–3 6.86 × 10–3 7.65 × 10–3 8.62 × 10–3 9.64 × 10–3 1.05 × 10–2 1.15 × 10–2 1.27 × 10–2 
1.0 1.19 × 10–2 1.33 × 10–2 1.46 × 10–2 1.62 × 10–2 1.82 × 10–2 2.06 × 10–2 2.32 × 10–2 2.62 × 10–2 
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These parameters (A, B, and C) were calculated by non-
linear multivariate regression analysis of experimental 
solubility data using equation 2. The calculated/Apelblat 
solubilities (x) were then calculated with the help of 
model parameters A, B, and C. The correlation and curve 
fitting between xe and x in various Transcutol + water 
mixtures from (298.15 to 333.15) K is presented Figures 
3a to 3c.  
The root mean square deviations (RMSD) be-
tween xe and x for crystalline GLZ were calculated 













   
   
  (3) 
Where, N is the number of data points which were 8 in 
the preset experiment. The values of regressed parame-
ters A, B, and C, R2, RMSD and standard errors (SE) of 
GLZ in various Transcutol + water co-solvent mixtures 
are listed in Table 3. The RMSD values for GLZ were 
observed in the range of (0.53 to 5.23) % in all co-
solvent mixtures investigated (Table 3). However, the 
values of SE were observed in the range of 0.005 to .023 
in all co-solvent mixtures. The RMSD value of GLZ was 
found to be lowest at w = 0.3 of Transcutol in Trans-
cutol + water mixture (0.53 %). However, the highest 
one was at w = 0.4 of Transcutol in Transcutol + water 
mixture (5.23 %). The R2 value for GLZ in pure water 
and pure Transcutol was found to be of 0.999 and 0.996, 
respectively (Table 3). The R2 values for GLZ in other 
co-solvent mixtures were observed in the range of 0.996 
to 0.999. Overall, the data of RMSD, SE and R2 in all 
sample matrices indicated the good fitting of experi-
mental data with the modified Apelblat model. 
 
Thermodynamic Parameters for GLZ Dissolution  
According to the thermodynamic principles, the dissolu-
tion of GLZ (solute) into a liquid can be expressed 
as:17,18,31 
Solid + liquid = solid-liquid at the equilibrium 
The standard molar enthalpy ( H o ) and entropy  
( S o ) of GLZ dissolution can be calculated using 
equations 4 and 5, respectively: 




   
 
 (4) 










Figure 3. Correlation and curve fitting of experimental mole
fraction solubilities (xe) of GLZ with the modified Apelblat
solubilities in various Transcutol + water co-solvent mixtures
from (298.15 to 313.15) K. Lower solubility curves (a), mid-
dle solubility curves (b), and higher solubility curves (c). 
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Where, R and T represent the universal gas constant and 
absolute temperature (expressed in K), respectively. The 
H∆ o  values for GLZ dissolution in mono-solvents (water 
and Transcutol) ranged from (30.60 to 30.86) kJ mol–1 and 
(14.31 to 23.20) kJ mol–1, respectively at various tempera-
tures. However, the H∆ o  values for GLZ dissolution in 
co-solvent mixtures were observed in the range of (16.86 
to 41.04) kJ mol–1. The H∆ o  values for GLZ dissolution 
in pure Transcutol were significantly reduced as compared 
to pure water. These results indicated that relatively low 
energy is required for solubilization of GLZ in pure Trans-
cutol as compared to pure water. Because of positive val-
ues of H∆ o  in mono-solvents and co-solvent mixtures, the 
dissolution of GLZ was assumed to be endothermic. 
Moreover, the S∆ o  values for GLZ dissolution in mono-
solvents and co-solvent mixtures were also observed as 
positive values (48.00 to 103.51) J mol–1 K–1 at each tem-
perature studied which also indicated that GLZ dissolution 
is an endothermic and an entropy-driven process. 
 
CONCLUSION 
In the present study, the mole fraction solubility of 
poorly soluble drug GLZ in pure water, pure Transcutol 
and various co-solvent mixtures at temperature range 
from (298.15 to 333.15) K was determined. The mole 
fraction solubility of GLZ was found to be increase 
exponentially with temperature in mono-solvents and 
co-solvent mixtures. The solubility of GLZ was signifi-
cantly enhanced in pure Transcutol and co-solvent mix-
tures as compared to pure water. The experimental data 
of GLZ was correlated and fitted well with the modified 
Apelblat model in mono-solvents and co-solvent mix-
tures. Based solubility data of this study, GLZ has been 
considered as soluble in pure Transcutol and practically 
insoluble in pure water. These studies indicated that 
Transcutol could be used as a co-solvent in formulation 
development of GLZ. 
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